Online First (2026)

Can a Benign Hematology Phenomenon Critically Impact the Neutropenia Status and Treatment of Patients With Cancer?

Neutropenia in oncology care usually has a disease-related or therapy-related etiology. However, for a population with a benign hematology phenomenon known as benign ethnic neutropenia (BEN) or Duffy-null associated neutrophil count (DAN...

Recombinant ADAMTS13: An Enzyme Replacement Therapy for the Management of Congenital Thrombotic Thrombocytopenic Purpura

Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare autosomal recessive condition that causes deficiency of the von Willebrand factor (vWF)-cleaving metalloprotease, ADAMTS13. Recombinant ADAMTS13 (rADAMTS13) is the first FD...

Narrative Medicine: A Clinical Tool for the Oncology Advanced Practitioner

Narrative medicine, a structured approach to engaging with patients’ stories, can help oncology advanced practitioners foster better engagement and understanding. This article details practical tools such as attentive listening, reflecti...

A Rare Case of Acute Hemolysis After Rasburicase Infusion

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic X-linked recessive disorder that results from mutations in the G6PD gene, which provides instructions for manufacturing the G6PD enzyme. G6PD deficiency can result in hemol...

Integrative Oncology Models of Care: Practice Patterns From NCCN Member Institutions

Patients with cancer frequently incorporate complementary modalities into their care. A survey of 29 NCCN Member Institutions revealed details on how integrative oncology services are delivered, including the types of services provided, ...

Clinical Posters From JADPRO Live 2025

Forty-four clinical posters focused on the role of the advanced practitioner were presented at JADPRO Live from October 23 to 26, 2025, in National Harbor, Maryland.